Come up with a name for your new list and we'll add to it:
Extremozyme raised a round of funding on July 20, 2006. Investors include
National Science Foundation.
Extremozyme is a company that received a STTR Phase I grant for a project entitled: DNA Assembly for Directed Expression of Industrial Enzymes Using a Novel Hyperthermophilic Genome. Their project aim…